Streetbeat News

Analyst Ratings

GS

Goldman Sachs (NYSE:GS) is set to release its Q4 earnings on Jan. 16, 2024, with an expected EPS of $3.41, up from $3.32 the previous year, and projected revenue of $10.80 billion, up from $10.59 billion. The company's Asset Management division closed the West Street Life Sciences I fund with $650 million in equity commitments. Shares fell 0.5% to $377.75 recently. Analysts from UBS, Morgan Stanley, Oppenheimer, JMP Securities, and Citigroup have provided various ratings and price targets for GS stock.

Portfolio Pulse from Avi Kapoor

January 16, 2024 | 5:30 am

BTCUSD

David Rosenberg, president of Rosenberg Research and former chief North American economist at Merrill Lynch, criticized Bitcoin's volatility and speculative nature, comparing it to gambling. He suggested that if investors want to get rich with cryptocurrencies, they should 'barbell' their holdings with lottery tickets. Rosenberg's comments come as Bitcoin ETFs gain regulatory approval in the U.S., despite Bitcoin's recent price drop from $49,000 to $44,000. Edward Jones' senior investment strategist, Mona Mahajan, also commented that Bitcoin ETFs could be a speculative part of an investor's portfolio.

Portfolio Pulse from Mehab Qureshi

January 16, 2024 | 4:49 am

CBSTF

GTBIF

JUSHF

Pablo Zuanic from Zuanic & Associates analyzed Virginia's upcoming recreational cannabis market, highlighting an advantageous start for medical incumbents like The Cannabist Company Holdings Inc., Green Thumb Industries Inc., and Jushi Holdings Inc. They may begin recreational sales by July 1, 2024, under the '2024 Cannabis Marketplace Act'. The report suggests limited competition and robust market economics similar to Minnesota's market. Political dynamics and social equity considerations add complexity, while the taxation framework focuses on supporting disadvantaged communities. Key regulatory dates and milestones are outlined, with various operational start dates for different licensees.

Portfolio Pulse from Nicolás Jose Rodriguez

January 15, 2024 | 6:33 pm

CTSH

Cognizant Tech Solns (NASDAQ:CTSH) is analyzed in comparison to its competitors in the IT Services industry. Key financial metrics such as P/E, P/B, P/S, ROE, EBITDA, Gross Profit, and Revenue Growth are evaluated. Cognizant's ratios are generally lower than the industry average, suggesting potential undervaluation. However, its lower ROE and revenue growth may indicate inefficiencies and a challenging sales environment. The company has a strong financial position with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 15, 2024 | 4:00 pm

MS

RJF

SCHW

Morgan Stanley (NYSE:MS) is set to report Q4 earnings on Jan. 16 with expected EPS of 99 cents and revenues of $11.61 billion. Despite a diverse revenue stream and conservative financial approach, MS stock has underperformed the SPY by 16% in 2023. Analysts focus on the company's resilience in volatile markets, with consensus ratings at Neutral and a price target of $86.36. Recent reviews from UBS, JPMorgan, HSBC, BofA Securities, and Barclays suggest higher price targets ranging from $94 to $116. MS stock closed at $89.70, down 0.89% on Friday.

Portfolio Pulse from Surbhi Jain

January 15, 2024 | 3:45 pm

DOGEUSD

Cryptocurrency analysts have identified a buy signal for Dogecoin (DOGE) on its 3-day chart using the TD Sequential indicator, suggesting a potential price reversal. Analyst Ali Martinez highlighted a support cluster at $0.074 and predicted a rally to $0.10 or higher if this level holds. Another analyst noted a bullish pennant pattern, indicating a possible 45-50% rally. This analysis follows the news of a physical Dogecoin token being launched into space aboard ULA's Vulcan Centaur rocket. Currently, DOGE is trading at $0.081, down 1.5% over the last 24 hours.

Portfolio Pulse from Mehab Qureshi

January 15, 2024 | 2:06 pm

GS

IBKR

MS

RJF

SCHW

Goldman Sachs (GS) is set to report Q4 earnings on Jan. 16 with expected EPS of $3.11 and revenue of $9.84 billion. GS stock gained 11.5% in 2023, trailing Interactive Brokers Group (IBKR) but outperforming Morgan Stanley (MS), Charles Schwab (SCHW), and Raymond James Financial (RJF). Analysts focus on GS's financial strength, trading revenue, and 2024 outlook amid potential for increased M&A activities. The consensus rating is a Buy with a target of $362.29, while UBS, JPMorgan, and Barclays have higher targets. GS shares closed slightly lower at $377.75.

Portfolio Pulse from Surbhi Jain

January 15, 2024 | 1:32 pm

GBTC

Bitcoin (BTC) is expected to drop to $38,000 according to 10x Research, following a 5% decline to $42,600 after the launch of spot ETFs in the U.S. The report cites a bearish RSI divergence and potential investor shift from the Grayscale Bitcoin Trust (GBTC) to lower-fee ETFs as reasons for the predicted decline.

Portfolio Pulse from Mehab Qureshi

January 15, 2024 | 8:11 am

BTCUSD

Former Goldman Sachs executive Raoul Pal predicts a crypto bull run, citing the introduction of spot market Bitcoin ETFs and a cleared out leverage as key factors. He anticipates volatility with potential 30%-35% pullbacks due to high demand and front-running of the ETF launch. Pal suggests the real run to all-time highs will start after a month or two of market chop.

Portfolio Pulse from Bibhu Pattnaik

January 14, 2024 | 6:06 pm

MAPS

Zuanic & Associates initiated coverage on WM Technology (NASDAQ:MAPS), a leading online cannabis marketplace, with a Neutral rating. They highlight MAPS' undervaluation at 0.6x sales compared to peers and its potential in the cannabis sector with a market cap of $142 million. The report details MAPS' enterprise value, growth prospects, strategic shifts, and outlines bull and bear scenarios. The bull scenario involves leveraging market position for growth, while the bear scenario includes risks of market saturation and strategic missteps.

Portfolio Pulse from Nicolás Jose Rodriguez

January 14, 2024 | 4:00 pm